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Increased levels of Porphyromonas gingivalis 
are associated with ischemic and hemorrhagic 
cerebrovascular disease in humans: an in vivo 
study
Janaina Salomon 1	
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ABSTRACT
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Objective: This study investigated the role of periodontal disease in the development of stroke or cerebral infarction in patients by evaluating the clinical periodontal 
conditions and the subgingival levels of periodontopathogens. Material and Methods: Twenty 
patients with ischemic (I-CVA) or hemorrhagic (H-CVA) cerebrovascular episodes (test 
group) and 60 systemically healthy patients (control group) were evaluated for: probing 
depth, clinical attachment level, bleeding on probing and plaque index. Porphyromonas 
gingivalis and Aggregatibacter actinomycetemcomitans	



in subgingival plaque samples by conventional and real-time PCR, respectively. Results: 
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depth, clinical attachment loss, bleeding on probing, plaque index and number of missing 
teeth when compared to control values (p<0.05, unpaired t-test). Likewise, the test group 
had increased numbers of sites that were contaminated with P. gingivalis (60%x10%; 
p<0.001; chi-squared test) and displayed greater prevalence of periodontal disease, with 
an odds ratio of 48.06 (95% CI: 5.96-387.72; p<0.001). Notably, a positive correlation 
between probing depth and the levels of P. gingivalis in ischemic stroke was found (r=0.60; 
!"

#A. actinomycetemcomitans DNA was 
not detected in any of the groups by conventional or real-time PCR. Conclusions: Stroke 
patients had deeper pockets, more severe attachment loss, increased bleeding on probing, 
increased plaque indexes, and in their pockets harbored increased levels of P. gingivalis. 
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cerebral hemorrhage or infarction. Early treatment of periodontitis may counteract the 
development of cerebrovascular episodes.
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INTRODUCTION
&
		

plaque rupture, two critical elements of cardiovascular 
pathogenesis leading to chronic disease burden 
and clinical events, result from systemic and 
$ 
'* 42. In general, 
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ischemic lesions. Moreover, an association between 
atherogenesis and Porphyromonas gingivalis and 
Aggregatibacter actinomycetemcomitans, both 

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
demonstrated8,14-16,26.
Periodontal disease, an asymptomatic 
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negative pathogens, including P. gingivalis and 
A. actinomycetemcomitans. In particular, when 
bacteria live in periodontal pockets lined with a 
thin and ulcerated epithelium as opposed to living 
on healthy gingival tissue with a robust epithelium, 
they can more effectively invade connective tissue, 
endothelial cells and the bloodstream. Additionally, 
these bacteria can induce thrombus formation by 
platelet aggregation degrading collagen28.
The main prerequisite for atherogenesis 
induction by periodontal disease may be the 
chronic systemic exposure to periodontopathic 
bacteria45 through bacteremia or endotoxemia, 
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cells within major blood vessels walls, preceding 
the formation of atherosclerotic plaques in cerebral 
vessels35. Another mechanism for atherogenesis is 
the induction of immunological processes, leading 
to increased levels of C-reactive protein (CRP), 
and increases in CRP even within the range of 
normal values is considered a reliable predictor 
of cardiovascular disease (CVD)12,46. In brief, 
periodontal disease is associated with CVDs in case-
controls and prospective studies, and, additionally, 
more severe attachment loss, deepened pockets 
and increased numbers of missing teeth in patients 
was positively correlated with CVD23,31,38,53,56. Some 
studies found the presence of P. gingivalis and A. 
actinomycetemcomitans in carotid atherosclerotic 
plaques, but the role of periodontopathogens in 
atheroma formation remains unclear. Recent CVD 
association studies, which use measurements that 
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generally exhibit stronger association than just 
clinical parameters of disease show5,40,42.
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study was to investigate the role of periodontal 
disease in the development of stroke or cerebral 
infarction in patients by evaluating the clinical 
periodontal conditions and the subgingival levels 
of periodontopathic bacteria.
MATERIAL AND METHODS
Sample selection
This study was approved by the Ethics Committee 
of Nossa Senhora da Conceição Hospital (Tubarão, 
SC, Brazil). Eighty patients, 30 to 80 years of age, 
were invited to participate in this study. Totally 
edentulous and/or pregnant patients and those 
patients whose formal consents were unobtainable 
were ineligible. The test group was composed of 
20 randomly selected patients (12 men, 8 women) 
from the Neurosurgery Division of the Intensive 
Care Unit between January 2006 and December 
GKQ
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

that looked for hospitalization without any previous 
history of a cerebrovascular accident (CVA) were 
included in the test group. To be included in the 
test group, patients had to be diagnosed with 
ischemic or hemorrhagic stroke for up to 4 days 
after hospitalization. The control group in this study 

	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men, 30 women) from the city of Bauru, São Paulo, 
Brazil seeking dental treatment at the Operative 
Dentistry Clinics of the Bauru School of Dentistry, 
University of São Paulo, during the same time period 
as the test group. Age and gender-matched patients 
without previous or current history of stroke were 
included in the control group.
Patients included in the test group were 
randomly procured at the city of Tubarão (SC), 
while those included in the control group were 
randomly selected among the population of Bauru 
(SP). Considering the demographic features 
of the different populations, a proportion of 1 
case to 3 controls was established, being in 
agreement with other studies that investigated the 
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conditions13,30,43.
Before data collection, patients answered a 
health questionnaire investigating possible risk 
factors for stroke, including: genetic predisposition, 
smoking, systemic alterations, arterial hypertension, 
and cardiovascular problems. Smoking was not 
evaluated in packs per years, but only evaluated 
whether the patient smoked. All patients were 
tested the same way.
Clinical examination
A single periodontist evaluated all patients by 
examining pocket probing depth (PPD) as measured 
by a manual periodontal probe (Hu-Friedy, USA), 
clinical attachment level (CAL), bleeding on/during 
probing (BOP)1 and a dichotomous plaque index 
(PLI). For statistical purposes, the presence of 
BOP and dental plaque was recorded as 1 and their 
"	$$	'	KM	;;$		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absence was recorded as 2. Additionally, although 
a whole mouth examination was performed, data 
were only recorded from the tooth showing the 

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the deepest site was evaluated after probing 3 
buccal and 3 palatal sites of all the teeth in the 
$ Y 
    *
one tooth in each sextant since most patients were 
lying on a bed unconscious making data collection 
arduous.
Subgingival plaque sample
Subgingival plaque samples were collected from 
the deepest site of each patient by introducing 
absorbent paper strips (PerioPaper, OraFlow Inc., 
NY, USA) for one minute into the gingival sulcus to 
the base of the pocket36. After removal, the material 
was stored in a sterile centrifuge tube containing 
500 μL of sterile distilled water and kept in a -20°C 
freezer until DNA extraction.
PCR analysis
For DNA extraction, samples were diluted 
1:2 with sterile distilled water and collected by 
centrifugation at 10,000× g for 5 min in a centrifuge 
at 4°C. The supernatant was discarded and the 
resulting pellet was washed two times with 1 mL 
of sterile distilled water, reconstituted with 100 μL 

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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Matrix (Bio-Rad Laboratories, Inc., Hercules, CA, 
USA), and incubated at 56°C for 30 min. Samples 
were then vortexed and boiled for 10 min. After 
centrifugation to remove unbroken cells and large 
debris (10,000× g for 3 min), the supernatant was 
collected for PCR analysis47.
For conventional PCR, a total of 50 μL 
of PCR mixture was analyzed. This mixture 
contained 10 μL of DNA sample, 5 μL of 10X 
PCR buffer, 1.25 units of Taq DNA polymerase 
(Promega, Madison, WI, USA), 0.2 mM each of 
deoxyribonucleotides, 1.0 μM of each primer, and 
1.5 mM of MgCl2 for P. gingivalis or 1.0 mM of MgCl2 
for A. actinomycetemcomitans47. DNA samples of 
P. gingivalis and A. actinomycetemcomitans were 
used as positive controls for amplifying reactions. 
These positive control samples were obtained from 
clinical isolations. For each set of primers, PCR 
was performed on sterile distilled water to check 
for DNA contamination (negative controls). Primer 
W{
[#
used as previously described4,55|}&
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products (9 μL) were analyzed using 2% agarose 
gel electrophoresis stained with 0.5 μg/mL ethidium 
bromide and photographed under ultraviolet light. A 
100 bp DNA ladder served as the molecular weight 
marker.
Real-time PCR was performed as previously 
described20 with a MiniOpticon system (Bio-Rad, 
~> }> !#> 
 !*/ MasterMix 
(Invitrogen Life Technologies, Carlsbad, CA, USA), 
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The positivity of bacteria detection in each sample 
was determined by comparison with positive and 
negative controls. The results were analyzed 
according to the cycle threshold (Ct) values. The 
number of bacteria in each sample and the Ct 
values were compared with a standardized curve 
composed from bacterial DNA ranging from 10-3 to 
109 bacteria.
Statistical analysis
Periodontal conditions of test and control 
groups were compared using an unpaired 
t-test. The prevalence of P. gingivalis and A. 
actinomycetemcomitans detected by conventional 
PCR was evaluated by a chi-squared test, with a 
$	
*P. gingivalis 
and A. actinomycetemcomitans Y 

by real-time PCR were not normally distributed 
and were found to be consistent with a log normal 
distribution in the case of P. gingivalis, and thus 
comparisons were made using the Kolmogorov-
Smirnov test. The risk of the occurrence of stroke 

'*

?
   
 W&#> 
	   
level. The correlation of periodontal parameters 
and the bacterial DNA levels were analyzed using 
!


RESULTS
In the test group of 20 patients, 7 (35%) 
patients developed hemorrhagic cerebrovascular 
episodes (H-CVE) and 13 (65%) patients developed 
ischemic cerebrovascular episodes (I-CVE). Data 
were obtained from 720 sites in the test group 
recovering from stroke and 2,158 sites in the control 
group (Table 1 depicts the periodontal conditions 
of the test and control groups). The prevalence of 
P. gingivalis and A. actinomycetemcomitans in the 
Target Sense Antisense 	Qo/U bp
A. actinomycetemcomitans ATGCCAACTTGACGTTAAAT AAACCCATCTCTGAGTTCTTCTTC 60 557
P. gingivalis AGGCAGCTTGCCATACTGCG ACTGTTAGCAACTACCGATGT 59 127
Figure 1- Primer sequences used in PCR tests and respective anneding temperature and the predicted amplicon size
TA - annealing temperature; bp - base pairs 
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subgingival microbiota of test and control groups 
evaluated by conventional PCR demonstrated that, 
respectively, 60% and 10% showed the presence of 
P. gingivalis (chi-squared test, p<0.001, Figure 2). 
A. actinomycetemcomitans DNA was not detected in 
any of the groups by conventional or real-time PCR.
The levels of P. gingivalis detected by real-time 
PCR are illustrated in Figure 3. Kolmogorov-Smirnov 
test showed a greater prevalence of P. gingivalis 
in the test group compared to the control group 
(p<0.001).
^	
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a PPD4 mm, which resulted in 19 (95%) diseased 
patients in the test group and 17 (28.3%) patients 
in the control group, resulting in an unadjusted 

KW
$K
to 387.72, p<0.001).
The test group included 7 smoking patients 
(35%), 5 of which developed I-CVE and 2 of which 
developed H-CVE (data not shown), while the 
control group included 17 smoking patients (28.3%) 
(Figure 4). An analysis showed that smoking did not 
	$
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the test group (chi-squared test, p<0.05), although 
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group with respect to smoking (data not shown).
By separating ischemic (I-CVE, n=13) and 
 Test Group /$	
Age (years) 59±13 48±10
PPD (mm) 2.6±2.4 2.4±1.5
CAL (mm) 5.1±4.4* 3.2±2.6
BOP (mm) 1.1±0.2* 1.7±0.8
PLI 1.0±0.0* 1.8±0.4
Teeth missing 2.4±1.6* 1.0±1.2
PPD - pocket probing depth (mm); CAL - clinical attachment level (mm); BOP - bleeding on probing (scores: 1 - presence; 
2 - absence); PLI – dichotomous plaque index (scores: 1- presence; 2 - absence). Test and control values are reported as 
	
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Table 1- Clinical periodontal conditions of test and control group patients (t-test)     
Figure 3-	 	 	 P. gingivalis DNA detected 
in subgingival plaque samples from test and control 
group subjects using real-time PCR. These data were 
not normally distributed and were found to be consistent 
with a log normal distribution, and thus comparisons were 
made using the Kolmogorov-Smirnov test and depicted on 
a log scale using median with the error bars representing 
a distribution between the 2.5th percentile and the 97.5th 
	 !"	 #$	 	 	 	
compared to control
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Figure 2- Detection of P. gingivalis, DNA using 2% agarose gel electrophoresis. The gel shows staining for P. gingivalis 
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2 to 10, 12 to 18, 20 to 21: positive staining for P. gingivalis DNA; columns 11 and 19 - negative samples for P. gingivalis
600 bp
500 bp
400 bp
300 bp
200 bp
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 Age *X 
A 63 I-CVE PD, H, S
B 52 H-CVE PD, H, S
C 36 H-CVE PD, H
D 56 I-CVE PD, H
E 55 H-CVE PD, H
F 72 H-CVE PD, H
G 48 I-CVE PD, H
H 61 I-CVE PD, H
I 69 I-CVE PD, H, S
J 71 H-CVE PD, H
K 59 I-CVE PD
L 35 H-CVE PD, H, S
M 56 I-CVE PD, H, S
N 78 I-CVE PD, H, S
O 80 I-CVE PD, H
P 57 I-CVE PD, H
Q 41 I-CVE PD, H
R 78 I-CVE PD, H, S
S 60 H-CVE PD
T 48 I-CVE H
Figure 4- Health questionnaire results   
I-CVE - ischemic cardiovascular episode; H-CVE - hemorrhagic cardiovascular episode; PD – periodontal disease; H – 
hypertension; S – smoker
 C/ C/ p-value
PPD (mm) 2.7±2.4* 2.3±2.4 0.009
CAL (mm) 5.4±4.4* 4.4±4.4 0.005
BOP (mm) 1.1±0.3 1.0±0.0 0.47
Teeth missing 2.8±1.6 2.3±2.4 0.12
P. gingivalis 1.2x106±2.2x106* 1.1x107±1.6x106 0.036
PPD - pocket probing depth (mm); CAL - clinical attachment level (mm); BOP - bleeding on probing (scores: 1 - presence; 
2 - absence); PLI- plaque index (scores: 1 - presence; 2 -absence); P. gingivalis - level of P. gingivalis. Test and control 
<					
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Table 2- Periodontal status and levels of P. gingivalis detected by real-time PCR in ischemic (I-CVE) and hemorrhagic 
(H-CVE) cardiovascular episode
Figure 5- Correlation between the quantity of P. gingivalis DNA detected in subgingival plaque samples and pocket probing 
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hemorrhagic (H-CVE, n=7) patients, increased PPD 
and CAL were observed in the I-CVE group, while 
increased levels of P. gingivalis were detected in the 
~+}W#



were observed between subgroups in BOP and 
number of missing teeth (p>0.05, Table 2). A 
positive correlation between PPD and the prevalence 
of P. gingivalis (r=0.60, p=0.03) was observed in 
	^+}W{
#	$	


was not observed in the H-CVE group (p=0.09, 
Figure 5B).
DISCUSSION
This study tested the hypothesis that periodontal 
disease is a risk factor for the development of stroke, 



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increases in CAL, BOP, PLI and P. gingivalis density 
compared to systemically healthy patients.
Some studies23,28,31,38,45,53,56 
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disease as a risk factor for the development of 
other medical conditions. The association between 
periodontal disease, tooth loss, and stroke was 
evaluated in epidemiological and prospective 
studies18,23,31,38,52,53,56, suggesting an association 
 	> 
 	 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study.
Periodontal disease remains a prevalent condition 
among many different populations2,29 /*>
more severe cases seem to be concentrated in 
20% of the population2, while individuals at older 
age groups seem to present nearly 8% of severe 
periodontal disease29. For the present study, it was 
observed that 17 out of 60 patients in the control 
group and 19 out of 20 patients in the test group 
presented at least one periodontal pocket 4 mm, 
resulting in a non-adjusted odds ratio of 48.06 
W 
$ K  G> [#
In brief, the cause-effect relationship between 
both conditions needs further investigation, but 
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with stroke showed more prevalent and severe 
periodontal lesions than systemically healthy 
patients.
Stroke has been associated with an incidence of 
fever resulting from respiratory tract infections35,38. 
Also, stroke may play a role in odontogenic 
alterations26, and can be regarded as a predisposing 
factor for cerebral conditions linked to bacterial 
endocarditis45. In the present study, 13 out of 
20 patients in the test group developed ischemic 
stroke and 7 out of 20 patients developed a 
hemorrhagic cerebrovascular event. Furthermore, 

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
hemorrhagic versus ischemic stroke, suggesting to 
that bacteria can lead not only atheromatous plaque 
formation8,14-16,26,28,32,41,45, but also the invasion of 
endothelial cells and injury to blood vessels23,35,38. 
Some studies suggested that the traditional role of 
lipid imbalance in the risk of cardiovascular diseases 
represents only one of the pathogenic pathways 
for CVD. In particular, a second pathway may be 
*
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can induce CVD by impairing endothelial function, 
promoting plaque formation and favoring plaque 
rupture by compromising the structural integrity 
of atheromatous plaques through the induction 
of vascular instability, leading to increased 
susceptibility for ischemic and hemorrhagic 
events25.
Dental sites with deep pockets harbor a large 
number of bacteria49, with a positive correlation 
between pocket probing depth and bacterial 
levels during ischemic stroke in the present study. 
Additionally, a greater incidence of ischemic stroke 
was previously observed in young patients with 
periodontal disease, particularly in those with 
decreased numbers of remaining teeth, however 
occurrence of this condition is unusual for younger 
age groups52,53.
Some studies have suggested an incidence of 
stroke in 10% of patients younger than 55 years39 
and 3.9% in patients younger than 45 years33. 
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stroke in young adults is not established, with some 
young patients (less than 45 years old) showing and 


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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et al. in 2001 found that out of 141 young patients 
with stroke, 32% had undetermined etiology58. For 
these reasons, the minimum and maximum age for 
inclusion of patients in the test and control groups 
was, respectively, 30 and 80 years. However, the 
average age of patients in the test group (59±13 
years) showed a trend to be older than the control 
group (48±10 years), and this trend might suggest 
that the majority of patients older than 30 years 
were developing stroke. In this study, only 2 
patients younger than 40 years of age had stroke.
Periodontal disease, in general, is quite prevalent 
in the world population. Estimates indicate that 
20% of the world population have severe cases of 
periodontal disease2. In a sample of 600 individuals 
aged 20 to 70 years, Hugoson and Jordan29 (1982), 
found an incidence of about 11% of marginal 
periodontal infectious disease in healthy individuals 
between 30 and 40 years of age29. This suggests 
that in the age group of 40 years old there will be 
approximately 89% of healthy individuals who have 
gingivitis or mild periodontal disease, with no signs 
of bone loss. Only 8% of individuals between 40 and 
70 years of age had severe periodontal disease29.
Although the number of patients included in 
the control group was relatively large compared 
to the number of patients in the test group yet in 
proportion, the increased number of patients in the 
control group provided more accurate information 
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concerning periodontal conditions in the otherwise 
healthy patients. However, increasing the number 
of patients included in the plaque sample, especially 
for the test group, could have also potentially 
provided more accurate information for the 
periodontal conditions for ischemic or hemorrhagic 
stroke. Overall, the results obtained in this study 

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groups (p<0.001), suggesting that periodontal 
disease is more prevalent and more severe in 
stroke than in systemically healthy patients, which 
is corroborated by other studies.
Periodontal examinations were performed by a 
single experienced periodontist, but a Kappa test was 
not performed to determine accuracy of this single 
examiner. Considering that periodontal examination 
of test group patients was performed bedside, 
time permitted only the tooth showing the deepest 
pocket at each sextant to be recorded, although a 
whole mouth examination was performed. Other 
risk factors for stroke were considered, in particular 
smoking. The results obtained in this study showed 
no differences between smoking and non-smoking 
patients.
Progression of per iodontal  d isease is 
characterized by acute bursts22,50, with the 
conversion of lymphocytes to neutrophils21,27. The 
etiology of periodontal disease is multifactorial, but 
primarily related to host response interactions and 
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 P. gingivalis 
and A. actinomycetemcomitans (the two bacteria 
which were investigated in this study)44. These 
bacteria have been extensively investigated due 
to their pathological properties, which include 
their capacity for: invading connective tissue, 
epithelial and endothelial cells; activating the 
complement cascade and immune system; and 
stimulating the synthesis of cytokines and other 
inflammatory mediators14,34,49. Recently, these 
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CVD patients8,14,16,26,32,57, suggesting a possible role 
for P. gingivalis and A. actinomycetemcomitans in 
the development of this lesion.
Both bacteria have their niche in the subgingival 
region, but they can also be found in lesser amounts 
in supragingival plaque samples24,49. However, 
their prevalence is not observed in all subgingival 
sites in the oral cavity, since healthy or inactive 
sites harbor extremely low populations of these 
bacteria24,51. Correspondingly, both bacteria are 
infrequently observed in the general population, 
but increased population densities are observed 
in patients with periodontal disease24,51. Although 
saliva is considered an easy, reliable and safe 
	Y

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*|}&47,55, some 
studies4,7,9 have suggested that a higher prevalence 
of bacteria is detected from subgingival microbiota, 
as found in this study.
In the present study, the presence and quantity 
of these bacteria in subgingival plaque samples 
were investigated by conventional and real-time 
PCR. The results obtained showed that P. gingivalis 
was more prevalent in the test group than in the 
control group, and that A. actinomycetemcomitans 
could not be detected in either group. The absence 
of observable A. actinomycetemcomitans is 
intriguing and needs further investigation since the 
primers used in the PCR worked well for the positive 
controls (ATCC 29522) and in a previous work by 
our group to detect A. actinomycetemcomitans from 
saliva samples of children47.
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with other reports in the literature18,23,26,31,38,52,53,56, 
suggesting an association of periodontal disease 
and tooth loss with an increased risk of stroke. The 
increased levels of P. gingivalis in stroke patients 
could suggest a role for periodontopathic bacteria in 
the formation of atheromatous plaque and vascular 
lesions, thus increasing the risk of cardiovascular 
and cerebrovascular diseases.
Chronic infections, such as periodontal disease, 
can contribute to atherogenesis by direct (platelet 
aggregation, invasion and injury to endothelial 
cells) or indirect (synthesis of intracellular adhesion 
molecules, production of antibodies against bacterial 
LPS and an imbalance of the immune system) 
pathways3,19. Namely, it was observed in this study 
that the I-CVE group had increased pocket depth 
and attachment loss when compared to the H-CVE 
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population density of P. gingivalis. The composition 
of the subgingival microbiota in patients with 
periodontal disease provides a significant and 
persistent bacterial challenge to the host body, 
which may gain access through ulcerated junctional 
epithelium lining the periodontal pockets6.
It was found that atherogenesis and plaque 
instability can be inferred by increased levels of 
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by C-reactive protein, which may be mediated by 
periodontal disease. Recent studies have indicated 
that periodontal treatment could reduce plasma 
levels of C-reactive protein and interleukin-610,11, 
improve endothelial function17,37,48,54 and improve 
periodontal health conditions, but without 
concomitant reduction in systemic levels of 
C-reactive protein when compared to the untreated 
control population.
Although the findings of the present study 
seem to be considerably relevant, other studies 
 *   	   
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pathogens in the development of atheromatous 
plaques, to more fully understand the mechanisms 
linking periodontal disease with cardiovascular 
diseases.
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CONCLUSIONS
Stroke patients had deeper pockets, more severe 
attachment loss, increased bleeding on probing, 
increased plaque indexes, and their pockets 
harbored increased levels of Porphyromonas 
gingivalis.	
	

disease is a risk factor for the development of 
cerebral hemorrhage or infarction. Early treatment 
of periodontitis may counteract the development of 
cerebrovascular episodes.
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